Those who trade on those press release numbers and hype are holding the bag on this stock. The debt is still huge and is the result of the previous two failed treatment centers. The facility is built out. They added 10 beds to an adjacent leased property with $2600 square feet, again done. That is why they are talking about letters of intent in the latest press release. That will take funding and they are tapped out. The June Leonite note secures the remaining assets of the Ehema (GRST) and they are now borrowing against future receipts. They are now in default on several notes including the $3.9 million in series "N" notes. Where does future capital come from for those LOIs let alone retiring any more debt. No dilution since they dumped 150 million shares on the February 28th press release, but they have notes sitting at .001 waiting for another opportunity. Cash flow is anemic and they continue to borrow. They need to fix the share structure and get back to selling shares in my opinion.
...The Company’s ARIA subsidiary continued its growth and had a $404,700.00 EBITDA for the second quarter which was a 117% increase over the first quarter of 2022...
Revenues Revenues were $1,138,032 and $96,158 for the three months ended June 30, 2022 and 2021, respectively,...
Operating expenses were $1,086,270 and $30,614 for the three months ended June 30, 2022 and 2021, respectively,...
Effective June 1, 2022, The Company entered into a Note Exchange Agreement whereby the convertible promissory notes entered into with Labrys Fund LP on May 7, 2021, with. A principal outstanding of $341,000, and on June 2, 2021 with a principal outstanding of $230,000 and accrued interest thereon of $25,300, were exchanged for a new Senior Secured Convertible Promissory note in the principal amount of $745,375, including an OID of $149,075. The Note matures on March 1, 2023, and bears interest at the minimum of 10% per annum or the Wall Street Journal quoted prime rate plus 5.75%.
The convertible note is secured by all of the assets of Ethema Health Corporation and Addiction Recovery Institute of America, LLC.
GRST - Good morning declaes....I had to Print Out this Post of your....-Really Love It!....
No, it looks nothing means much to you if it's coming from GRST or Mr Leon... LOL
- Revenues of $1,138,000 in Q2 doesn't mean much to you. - Revenues of $8,000,000 in the next 12 months doesn't mean much - EBITDA of 404,000 doesn't mean much - EBITDA of 35% over revenues doesn't mean much - An EBITDA up 117% from last Q doesn't mean much to you - a revenue increase of 13% for the second quarter 2022 over the first quarter 2022, doesn't mean much to you. - Expanding of 30% beds from the start of Q3 doesn't mean much - Expanding of workforce with 2,200% from 2 to 44 people doesn't mean much to you - the Company's new wholly owned subsidiary, PB Billing LLC, which started operating in May 2022, doesn't mean much to you - Extending debts with a conversion price of $0.01 from $0.0009-$0.0025 doesn't mean much to you - The option to purchase the building at 950 Evernia Street, West Palm Beach, doesn't mean much to you - No diluting since March doesn't mean much to you. - RS is not even on the horizon doesn't mean much to you...
LOL, All the hype with disinformation and false hoods haven't worked. Not working today because many know what the direct offering means. No one will buy direct offering shares until they clean up the share structure and get a better story line. reverse split will be up to bat soon and it wouldn't surprise me if they aren't dumping new shares today as a final money grab from this group of shareholders.
News 
Market Data 
Discover 
